Global Cancer Drug Therapy Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027

Report ID: BMRC 1537 | Number of pages: 198 | Publish Date: Nov 2019 | Publisher: BMRC | Category: Lifesciences and Healthcare
Our final report will cover impact analysis of COVID-19 outbreak
New

The Detailed Market intelligence report on the Global Cancer Drug Therapy Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Cancer Drug Therapy Market place for the forecast 2021– 2027.

Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.

The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.

Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.

In this report, 2019 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Cancer Drug Therapy. This report studies the global market size of Cancer Drug Therapy, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Cancer Drug Therapy sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs

Market Segment by Product Type

Targeted Therapy
Chemotherapy
Immunotherapy

Market Segment by Application

Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)

Key Regions split in this report: breakdown data for each region.

United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

To analyze and research the Cancer Drug Therapy status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

To present the key Cancer Drug Therapy manufacturers, presenting the sales, revenue, market share, and recent development for key players.

To split the breakdown data by regions, type, companies and applications

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends, drivers, influence factors in global and regions

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market


Interested in this report?
Get your sample now!
Table of Content
1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Cancer Drug Therapy Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Cancer Drug Therapy Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Cancer Drug Therapy Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Cancer Drug Therapy Market Overview: Quantitative Analysis
3.1. Global Cancer Drug Therapy Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2027
3.2. Global Cancer Drug Therapy Market Revenue Market Share (%), 2014- 2027
3.3. Global Cancer Drug Therapy Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2027
3.4. Global Cancer Drug Therapy Market Sales Market Share (%), 2014- 2027
4. Chapter – Global Cancer Drug Therapy Market Analysis: Segmentation By Type
5. Chapter – Global Cancer Drug Therapy Market Analysis: Segmentation By Application
6. Chapter - Global Cancer Drug Therapy Market Analysis: By Manufacturer 
6.1. Global Cancer Drug Therapy Market Revenue (USD Million), by Manufacturer, 2014 - 2027
6.2. Global Cancer Drug Therapy Market Share (%), by Manufacturer, 2018
6.3. Global Cancer Drug Therapy Market Sales (Number of Units), by Manufacturer, 2014 - 2027
6.4. Global Cancer Drug Therapy Market Share (%), by Manufacturer, 2018
6.5. Global Cancer Drug Therapy Market Price (USD/Unit), by Manufacturer, 2014 - 2027
6.6. Global Cancer Drug Therapy Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2027
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
7. Chapter –Cancer Drug Therapy Market: Regional Analysis
7.1. North America
7.1.1. North America Cancer Drug Therapy Market Revenue (USD Million) and Growth Rate (%), 2014 – 2027.
7.1.2. North America Cancer Drug Therapy Market Revenue (USD Million) By Country, 2014 – 2027.
7.1.3. North America Cancer Drug Therapy Revenue Market Share (%) By Country, 2014 – 2027.
7.1.4. North America Cancer Drug Therapy Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2027.
7.1.5. North America Cancer Drug Therapy Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2027.
7.1.6. North America Cancer Drug Therapy Market Sales (Number of Units) and Growth Rate (%), 2014 – 2027.
7.1.7. North America Cancer Drug Therapy Market Sales (Number of Units) By Country, 2014 – 2027.
7.1.8. North America Cancer Drug Therapy Sales Market Share (%) By Country, 2014 – 2027.
7.1.9. North America Cancer Drug Therapy Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2027.
7.1.10. North America Cancer Drug Therapy Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2027.
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Chapter - Company Profiles
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.